/index.php?option=com_iwpfile&file=/dir_04/he2004_2591.pdf


Democrats Bill on Clinical Trial Bill Summary

<!--

_site: health

_doc_type: ex

_title: Democrats Unveil Clinical Trial Legislation]

_doc_number: he2004_2590

_summary: ]

_creation_date: 10/07/2004

_pub_date: 10/18/2004

_priority: 1

_doc_format: as

_subj_cat: drugalert

_name_location:

_FDA: 10/22/2004

_OSHA:

_CMS:



For Immediate Release

October 18, 2004

Contacts: Laura Gore

cell:

410-733-4109

Colleen Hughes

cell: 415-559-8225

FLU VACCINE SHORTAGE COULD RESULT IN SIGNIFICANT PATIENT DEATHS, UNLESS SWIFT ACTIONS ARE TAKEN

---

ACEP ISSUES CALL FOR ACTION TO INCREASE SURGE CAPACITY IN NATION'S EMERGENCY DEPARTMENTS



SENATOR EDWARD M. KENNEDY STATEMENT ON THE FLU ANNOUNCEMENT MADE THIS AFTERNOON AT HHS

October 15, 2004

For Immediate Release

Contact: David Smith / Jim Manley

(202) 224-2633

Today's conference makes clear the full extent of the flu vaccine fiasco. Under George Bush's watch, FDA stood idly by as problems in vaccine production went unchecked. Because of this neglect, over 40 million doses of contaminated vaccine will have to be discarded, while patients at risk must go without the protection that a safe vaccine provides.

<!--



FDA Talk Paper

T04-42

October 18, 2004

Media Inquiries: 301-827-6242

Consumer Inquiries: 888-INFO-FDA

FDA Approves Temporary Artificial Heart

The Food and Drug Administration (FDA) has approved a partial artificial heart intended to keep people alive in the hospital while they are awaiting a heart transplant.



Pfizer Provides Information to Healthcare Professionals About Its Cox-2 Medicine Bextra® (Valdecoxib)

NEW YORK, October 15, 2004 -- In view of the increased focus on alternative treatment options for people with arthritis, Pfizer is providing information to healthcare professionals about its COX-2 product Bextra® (valdecoxib).



MEDICARE NEWS

FOR IMMEDIATE RELEASE

CMS Media Affairs

October 18, 2004

MEDICARE BENEFICIARIES WILL SOON BE ABLE TO RESOLVE MEDICARE APPEALS FASTER

Centers for Medicare & Medicaid Services Administrator Mark B. McClellan, M.D., Ph.D., today announced a key step in helping Medicare beneficiaries resolve their appeals more quickly and efficiently, as part of a comprehensive overhaul of the Medicare claims appeals system.



Press Release

For Immediate Release October 15, 2004 Contact: CDC Media Relations 404-639-3286

CDC/Aventis Pasteur Collaborate To Ship More Than 2 Million Doses of Influenza Vaccine to Providers Who Serve High-Priority Groups

  • Veterans Administration
  • Long-term Care Facilities/Acute Care Hospitals
  • State Public Health Officials
  • Va


Table of Contents FDA Press Release On 2004 Produce Safety Action Plan Product Safety Plan

<!--

_site: health

_doc_type: ex

_title: FDA Releases Produce Safety Action Plan For 2004]

_doc_number: he2004_2583

_summary: ]

_creation_date: 10/18/2004

_pub_date: 10/18/2004



/index.php?option=com_iwpfile&file=/dir_04/he2004_2582.pdf


Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.